PharmaEssentia

Price Chart

Risk-Adjusted Performance

PharmaEssentia (6446) Price Performance

PharmaEssentia (6446) trades on TW in TWD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at TWD620.00, down 3.13% from the previous close.

Over the past year, 6446 has traded between a low of TWD400.58 and a high of TWD779.00. The stock has gained 21.2% over this period. It is currently 20.4% below its 52-week high.

PharmaEssentia has a market capitalization of $246.45B, with a price-to-earnings ratio of 48.82 and a dividend yield of 0.16%.

About PharmaEssentia

PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.